Gail K Naughton
CIK 1297506 · See Remarks · last filed 2025-11-05
Gail K Naughton is a corporate insider who has filed 59 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for TXMD, was dated Nov 5, 2025. Across all open-market trades the lifetime net is −$18.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.7K
5
59
-$18.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TXMD | Director | 8,500 | $2.20 | $18.7K | -$20.6K | 9 | 2025-11-05 |
| CVM | Director | — | $1.08 | — | $0 | 1 | 2023-08-10 |
| Histogen Inc. (HSTO) Delisted | See Remarks | 426,526 | $0.21 | $91.7K | $0 | 2 | 2021-01-15 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 2,400 | — | — | $2.1K | 6 | 2017-11-29 |
| Celera CORP (CRA) Delisted | Director | — | — | — | $0 | 3 | 2010-05-27 |
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-05 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | TXMD | Exer (M) | +8,500 | $0 | EDGAR |
| 2023-08-10 | CVM | Grant (A) | — | $0 | EDGAR |
| 2023-07-19 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2022-12-08 | TXMD | Sell (S) | −3,922 | -$20.6K | EDGAR |
| 2022-10-03 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2022-08-22 | TXMD | Exer (M) | +1,984 | $0 | EDGAR |
| 2021-08-12 | TXMD | Exer (M) | +96,864 | $0 | EDGAR |
| 2021-07-02 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2021-01-15 | Histogen Inc. (HSTO) Delisted | Grant (A) | — | $0 | EDGAR |